Results 31 to 40 of about 2,162 (171)

Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report

JA Clinical Reports, 2022
Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis.
Satoshi Uchida, Daiki Takekawa, Eiji Hashiba, Reiko Kudo, Kazuyoshi Hirota   +4 more
doaj   +1 more source

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

Frontiers in Medicine, 2022
ObjectiveHypotension is common in propofol anesthesia. Whether remimazolam could reduce intraoperative hypotension remains unknown. We therefore tested the primary hypothesis that remimazolam reduces the incidence of intraoperative hypotension compared ...
Yuwei Qiu, Yuwei Qiu, Wei Gu, Mingye Zhao, Yunyun Zhang, Jingxiang Wu, Jingxiang Wu   +6 more
doaj   +1 more source

Anesthesia Management of a Liver Transplant Recipient with Remimazolam

Case Reports in Anesthesiology, 2023
Background. Intraoperative anesthetic requirements might be altered due to the modulated metabolic function in living donor liver transplant recipients. Remimazolam may provide appropriate anesthesia in patients with cirrhosis.
Takashi Kawasaki, Takafumi Oyoshi, Naoyuki Hirata   +2 more
doaj   +1 more source

Efficacy and Safety of Remimazolam in Endoscopic Sedation—A Systematic Review and Meta-Analysis

Frontiers in Medicine, 2021
Background: The aim of this systematic review and meta-analysis was to investigate the efficacy and safety of remimazolam in clinical endoscopic procedure sedation.Methods: The authors searched the databases of PubMed, Embase, and Cochrane Library for ...
Xianlin Zhu, Hongbai Wang, Su Yuan, Yinan Li, Yuan Jia, Zhe Zhang, Fuxia Yan, Zaiping Wang   +7 more
doaj   +1 more source

Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test—A Case Report and Literature Review

Medicina, 2023
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test.
Sangho Lee, Joyoung Park, Na Hei Kim, Halin Hong, Kyoung Hee Sohn, Hee Yong Kang, Mi Kyeong Kim, Ann Hee You   +7 more
doaj   +1 more source

Remimazolam-Based Anesthesia in Patients with Heart Failure Due to Mitral Regurgitation and Low Left Ventricular Function: A Case Series

Medicina, 2023
Background and Objectives: Remimazolam is a new ultrashort-acting benzodiazepine anesthetic. Remimazolam appears to be useful in patients with severe valvular disease because of its minimal cardiovascular impact.
Atsuhiro Kitaura, Hiroatsu Sakamoto, Shinichi Hamasaki, Shota Tsukimoto, Yasufumi Nakajima   +4 more
doaj   +1 more source

A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation

Clinical and Translational Science, 2021
The clinical effects of remimazolam (an investigational, ultra‐short acting benzodiazepine being studied in procedural sedation) were measured using the Modified Observer’s Assessment of Awareness/Sedation Scale (MOAA/S).
Jie Zhou, Laura Curd, Lauren R. L. Lohmer, Natalie Delpratt, Joachim Ossig, Frank Schippers, Thomas Stoehr, Virginia D. Schmith   +7 more
doaj   +1 more source

Intraoperative responses of motor evoked potentials to the novel intravenous anesthetic remimazolam during spine surgery: a report of two cases

JA Clinical Reports, 2020
Background Remimazolam is a novel short-acting benzodiazepine characterized by metabolism independent from organ function. We report intraoperative MEP responses of two patients who underwent spine surgery under general anesthesia using remimazolam. Case
Takashi Kondo, Yukari Toyota, Soshi Narasaki, Tomoyuki Watanabe, Hirotsugu Miyoshi, Noboru Saeki, Yasuo M. Tsutsumi   +6 more
doaj   +1 more source

Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients

Frontiers in Medicine
BackgroundRemimazolam is a new ultra-short-acting benzodiazepine for procedural sedation and general anaesthesia, characterised by rapid onset of action, quick recovery, and organ-independent metabolism.
Jin-Chao Song, Xiao-xi Wang, Xiang Fu, Wei Chen, Shu-heng Tang, Fang Deng, Hua Yang, Wen Liu   +7 more
doaj   +1 more source

Remimazolam Anesthesia for Thyroid Surgery

Case Reports in Anesthesiology, 2023
Background. Critical upper airway obstruction, hematoma formation, and recurrent laryngeal nerve palsy have been reported as postoperative complications of thyroid surgery. Although remimazolam may reduce the risk of these complications, the efficacy of flumazenil with remimazolam has not been reported.
Sae Nakagawa, Tomoharu Shakuo, Sakurako Matsudo, Hiroaki Soda, Kenji Shida   +4 more
openaire   +3 more sources